Search results

13 results for lithium carbonate

Sorted by Relevance . Sort by Date

Source: Database of Abstracts of Reviews of Effects - DARE Remove Source: Database of Abstracts of Reviews of Effects - DARE filter
Source: British Association for Psychopharmacology - BAP Remove Source: British Association for Psychopharmacology - BAP filter
Source: Clinical Knowledge Summaries - CKS Remove Source: Clinical Knowledge Summaries - CKS filter
Source: TravelHealthPro Remove Source: TravelHealthPro filter

Showing results 11 to 13. View options for downloading these results.

Add this result to my export selection

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP (PDF)

Source:

British Association for Psychopharmacology - BAP (Remove filter)

Published by British Association for Psychopharmacology, 28 May 2012

These guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on their pharmacological management. They are based...

Read Summary

Type:

Guidance (Add filter)
Add this result to my export selection

Outcome of pharmacological treatments of pathological gambling: a review and meta-analysis

Source:

Database of Abstracts of Reviews of Effects - DARE (Remove filter)

02 September 2009

Bupropion, Fluvoxamine, Topiramate, Paroxetine, Nalmefene, Escitalopram, Lithium carbonate, valproate, Naltrexone, Nefazodone,...

Type:

Systematic Reviews (Add filter)
Add this result to my export selection

Treatment of attention-deficit/hyperactivity disorder

Source:

Database of Abstracts of Reviews of Effects - DARE (Remove filter)

30 September 2001

biofeedback, efamol, haloperidol, hydroxyzine, imipramine, L-amphetamine, lithium carbonate, lethylphenidate, nicotine, nothing (e.g....

Type:

Systematic Reviews (Add filter)

Page 2 of 2